Skip to main content
Caplight Logo









Mytos

Mytos

Private
LondonHealthcare & Life Scienceshttps://www.mytos.bio/

Last Round

Series A

Nov 30, 2023

Est. Valuation

$1.71M

Total Funding Raised

$21.24M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Mytos is a biotechnology company that has developed a fully automated platform for human cell manufacturing, designed to serve pharmaceutical and biotechnology businesses.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

automated cell culturecell therapy manufacturingCDMOcontract development and manufacturing organizationbiotech automationlab automationregenerative medicinebioprocessingrobotic cell culturecell line developmentdrug discoverybiotech hardwareclinical grade manufacturingbio-manufacturinglab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mytos Comparables

Compare Mytos with similar companies based on industry and business-model similarity.

Mytos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Multiply Labs
88%
Cellular Origins
86%
Ori Biotech
84%

Mytos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 30, 2023
AcceleratorAug 20, 2018
SeedAug 1, 2018
AcceleratorJun 1, 2018

Key People

Founding team and executive leadership

Ali Afshar

CEO Co-Founder

Founding Team

Mytos Investors

Notable investors and investment history

Mytos investors
InvestorRounds
CathexisSeed
Deep Science VenturesSeed
Acequia CapitalSeed
Hoxton VenturesSeed
AiSprouts VCSeed
IQ CapitalSeries A
Buckley VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 151% MoM, reaching 15.9K.

  • Sep 3, 2025

    Partnered with Novadip to power next-generation cell therapy trials.

Mytos Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mytos Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mytos's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range48
Year Founded2016
Last FundingNov 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?